Retraction

Linc00472 suppresses breast cancer progression and enhances doxorubicin sensitivity through regulation of miR-141 and programmed cell death 4

Paper Information

Record ID:
25423
Publication Date:
February 23, 2018
Retraction Date:
February 02, 2021 (4.8 years years ago)
Article Type:
Publisher:
Royal Society of Chemistry (RSC)
Open Access:
Yes
PubMed ID:
Not indexed in PubMed
Retraction PubMed ID:
Not indexed in PubMed

Retraction Details

Nature of Retraction:

Retraction

Retraction Notice:
10.1039/D1RA90067F
Additional Notes:

see also: https://blogs.rsc.org/ra/2021/01/21/rsc-paper-mill-retractions/?doing_wp_cron=1611230128.9542400836944580078125

Citations (5)

5
Total Citations
2
Post-Retraction
(40.0%)
2
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
2 Within 1 year
0 After 2+ years
321 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Long Noncoding RNA 00472: A Novel Biomarker in Human Diseases
Danyang Ren, Xin-rong Yuan, Cai‐Xia Tu et al. (11 authors)
Frontiers in Pharmacology Open Access
Published: Dec 2021
5 citations
321 days after retraction
The role of miRNAs and lncRNAs in conferring resistance to doxorubicin
Mohammad Taheri, Bashdar Mahmud Hussen, Farhad Tondro Anamag et al. (6 authors)
Journal of drug targeting
Published: Mar 2021
12 citations
57 days after retraction
Identification of an eight-lncRNA prognostic model for breast cancer using WGCNA network analysis and a Cox‑proportional hazards model based on L1-penalized estimation
Zhenbin Liu, Menghu Li, Hua Qi et al. (5 authors)
International Journal of Molecular Medicine Open Access
Published: Aug 2019
42 citations
546 days before retraction
Linc00472 suppresses proliferation and promotes apoptosis through elevating PDCD4 expression by sponging miR-196a in colorectal cancer
Yafei Ye, Shengnan Yang, Yanping Han et al. (8 authors)
Aging Open Access
Published: Jun 2018
49 citations
957 days before retraction